Quarterly report pursuant to Section 13 or 15(d)

Schedule of Changes in Fair Value of Level 3 Valued Instruments (Details)

v3.22.2.2
Schedule of Changes in Fair Value of Level 3 Valued Instruments (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]        
Additions $ (250)
2020 Convertible Note [Member]        
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]        
Beginning Balance      
Additions       3,746
Measurement adjustments       4
Settlement       (3,750)
Ending Balance    
Warrants [Member]        
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]        
Beginning Balance      
Additions       635
Measurement adjustments       (214)
Settlement       (421)
Ending Balance    
Embedded Derivative [Member]        
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]        
Beginning Balance       1,690
Additions       325
Measurement adjustments       250
Settlement       (2,265)
Ending Balance    
Vivo Pharm Pty Ltd [Member]        
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]        
Beginning Balance     11,000  
Additions      
Measurement adjustments     (5,528)  
Settlement      
Ending Balance $ 5,472   $ 5,472